Intranasal irbesartan reverts cognitive decline and activates the PI3K/AKT pathway in an LPS-induced neuroinflammation mice model.
第一作者:
Filipa,Gouveia
第一单位:
Laboratory of Pharmacology, Faculty of Pharmacy, University of Coimbra, Coimbra, Portugal; Coimbra Institute for Biomedical Imaging and Translational Research (CIBIT), Institute of Nuclear Sciences Applied to Health (ICNAS), University of Coimbra, Coimbra, Portugal; Department of Pharmacology, Toxicology and Therapeutic Chemistry, Faculty of Pharmacy and Food Science, Universitat de Barcelona, Barcelona, Spain; Institute of Neurosciences, Universitat de Barcelona, Barcelona, Spain.
作者:
医学主题词
人类(Humans);男(雄)性(Male);小鼠(Mice);动物(Animals);血管紧张素转换酶抑制药(Angiotensin-Converting Enzyme Inhibitors);原癌基因蛋白质c-akt(Proto-Oncogene Proteins c-akt);脂多糖类(Lipopolysaccharides);磷酸肌醇3-激酶类(Phosphatidylinositol 3-Kinases);血管紧张素受体拮抗剂(Angiotensin Receptor Antagonists);投药, 鼻内(Administration, Intranasal);阿尔茨海默病(Alzheimer Disease);消炎药(Anti-Inflammatory Agents)
DOI
10.1016/j.intimp.2023.111471
PMID
38199198
发布时间
2024-02-08
- 浏览0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



